Logo image of CREE

Cree Inc (CREE) Stock Fundamental Analysis

NASDAQ:CREE -

79.12
-1.61 (-1.99%)
Last: 10/1/2021, 8:12:25 PM
79.78
+0.66 (+0.83%)
After Hours: 10/1/2021, 8:12:25 PM
Fundamental Rating

3

CREE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. While CREE seems to be doing ok healthwise, there are quite some concerns on its profitability. CREE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CREE has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -15.2%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -59.72%
PM (TTM) -99.68%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

6

2. Health

2.1 Basic Checks

There is no outstanding debt for CREE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 3.69 indicates that CREE is not in any danger for bankruptcy at the moment.
There is no outstanding debt for CREE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.69
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 3.29 indicates that CREE has no problem at all paying its short term obligations.
A Quick Ratio of 2.92 indicates that CREE has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 2.92

More info and screens

4

3. Growth

3.1 Past

CREE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -95.56%.
Looking at the last year, CREE shows a very negative growth in Revenue. The Revenue has decreased by -41.85% in the last year.
The Revenue for CREE have been decreasing by -20.13% on average. This is quite bad
EPS 1Y (TTM)-95.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.78%
Revenue 1Y (TTM)-41.85%
Revenue growth 3Y-17.17%
Revenue growth 5Y-20.13%
Sales Q2Q%-78.27%

3.2 Future

CREE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 70.46% yearly.
Based on estimates for the next years, CREE will show a very strong growth in Revenue. The Revenue will grow by 37.07% on average per year.
EPS Next Y-2.7%
EPS Next 2Y44.34%
EPS Next 3Y59.04%
EPS Next 5Y70.46%
Revenue Next Year6.86%
Revenue Next 2Y26.16%
Revenue Next 3Y31.93%
Revenue Next 5Y37.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CREE Yearly Revenue VS EstimatesCREE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
CREE Yearly EPS VS EstimatesCREE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CREE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CREE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CREE Price Earnings VS Forward Price EarningsCREE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -52.28
CREE Per share dataCREE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as CREE's earnings are expected to grow with 59.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.34%
EPS Next 3Y59.04%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CREE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Cree Inc

NASDAQ:CREE (10/1/2021, 8:12:25 PM)

After market: 79.78 +0.66 (+0.83%)

79.12

-1.61 (-1.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners1.99%
Ins Owner Change0%
Market Cap9.17B
Analysts75
Price Target102.47 (29.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 17.44
P/FCF N/A
P/OCF N/A
P/B 4.33
P/tB N/A
EV/EBITDA -52.28
EPS(TTM)-0.88
EYN/A
EPS(NY)-0.9
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.54
BVpS18.26
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.2%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -59.72%
PM (TTM) -99.68%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.29
Quick Ratio 2.92
Altman-Z 3.69
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-95.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.78%
EPS Next Y-2.7%
EPS Next 2Y44.34%
EPS Next 3Y59.04%
EPS Next 5Y70.46%
Revenue 1Y (TTM)-41.85%
Revenue growth 3Y-17.17%
Revenue growth 5Y-20.13%
Sales Q2Q%-78.27%
Revenue Next Year6.86%
Revenue Next 2Y26.16%
Revenue Next 3Y31.93%
Revenue Next 5Y37.07%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A